BMPR1B |
BMPR1B: Bone morphogenetic protein receptor type IB precursor |
ACVR2A |
ACVR2A, ACVR2: Activin receptor type-2A precursor |
3.6 |
Evidence |
O
|
INHBB |
INHBB: Inhibin beta B chain precursor |
INHBC |
INHBC: Inhibin beta C chain precursor |
3.6 |
Evidence |
O
|
BMPR1B |
BMPR1B: Bone morphogenetic protein receptor type IB precursor |
BMPR1A |
BMPR1A, ACVRLK3, ALK3: Bone morphogenetic protein receptor type IA precursor |
3.6 |
Evidence |
O
|
MAF |
MAF: Transcription factor Maf |
FOS |
FOS, G0S7: Proto-oncogene protein c-fos |
3.6 |
Evidence |
|
RPL7 |
RPL7: 60S ribosomal protein L7 |
VDP |
DKFZp451D234: Putative uncharacterized protein DKFZp451D234 |
3.597 |
Evidence |
O
|
HSPD1 |
|
HSP90AA1 |
Hsp89-alpha-delta-N |
3.595 |
Evidence |
O
|
COPS5 |
COPS5, CSN5, JAB1: COP9 signalosome complex subunit 5 |
COPS7A |
COPS7A, CSN7A, DERP10: COP9 signalosome complex subunit 7a |
3.58 |
Evidence |
|
YWHAB |
YWHAB: 14-3-3 protein beta/alpha |
SRC |
SRC, SRC1: Proto-oncogene tyrosine-protein kinase Src |
3.575 |
Evidence |
|
COPS6 |
COPS6, CSN6, HVIP: COP9 signalosome complex subunit 6 |
COPS3 |
COPS3, CSN3: COP9 signalosome complex subunit 3 |
3.572 |
Evidence |
|
TCF3 |
TCF3, E2A, ITF1: Transcription factor E2-alpha |
LMO2 |
LMO2, RBTN2, RBTNL1, RHOM2, TTG2: Rhombotin-2 |
3.547 |
Evidence |
|
EIF2S3 |
EIF2S3, EIF2G: Eukaryotic translation initiation factor 2 subunit 3 |
LSM5 |
LSM5: U6 snRNA-associated Sm-like protein LSm5 |
3.545 |
Evidence |
O
|
EIF2S3 |
EIF2S3, EIF2G: Eukaryotic translation initiation factor 2 subunit 3 |
LSM2 |
LSM2, C6orf28, G7b: U6 snRNA-associated Sm-like protein LSm2 |
3.545 |
Evidence |
O
|
TXK |
TXK, PTK4: Tyrosine-protein kinase TXK |
SH2D2A |
SH2D2A, SCAP, TSAD, VRAP: SH2 domain-containing protein 2A |
3.525 |
Evidence |
|
FPR1 |
FPR1: fMet-Leu-Phe receptor |
GNAI2 |
Galphai2 protein |
3.525 |
Evidence |
|
RAF1 |
RAF1, RAF: RAF proto-oncogene serine/threonine-protein kinase |
BAD |
BAD, BBC6, BCL2L8: Bcl2 antagonist of cell death |
3.51 |
Evidence |
|
RGL2 |
RGL2, RAB2L: Ral guanine nucleotide dissociation stimulator-like 2 |
RAP1B |
RAP1B, OK/SW-cl.11: Ras-related protein Rap-1b precursor |
3.497 |
Evidence |
|
CAV1 |
CAV1, CAV: Caveolin-1 |
SRC |
SRC, SRC1: Proto-oncogene tyrosine-protein kinase Src |
3.495 |
Evidence |
|
BRCA1 |
BRCA1, RNF53: Breast cancer type 1 susceptibility protein |
RAD51 |
RAD51, RAD51A, RECA: DNA repair protein RAD51 homolog 1 |
3.477 |
Evidence |
|
BARD1 |
BARD1: BRCA1-associated RING domain protein 1 |
CDC2 |
CDC2: Cell division control protein 2 homolog |
3.477 |
Evidence |
O
|
PCNA |
PCNA: Proliferating cell nuclear antigen |
CDC25C |
CDC25C: M-phase inducer phosphatase 3 |
3.477 |
Evidence |
|
PTPN11 |
IPI00298347 |
JAK1 |
|
3.47 |
Evidence |
|
VAV1 |
VAV1, VAV: Proto-oncogene vav |
CASP3 |
CASP3, CPP32: Caspase-3 precursor |
3.47 |
Evidence |
|
CREBBP |
CREBBP, CBP: CREB-binding protein |
CSNK2A1 |
CSNK2A1: CSNK2A1 protein |
3.452 |
Evidence |
|
CDK4 |
CDK4: Cell division protein kinase 4 |
SMAD3 |
SMAD3, MADH3: Mothers against decapentaplegic homolog 3 |
3.452 |
Evidence |
O
|
SMAD3 |
SMAD3, MADH3: Mothers against decapentaplegic homolog 3 |
NUP153 |
IPI00514528 |
3.452 |
Evidence |
|